Literature DB >> 8773952

Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells.

P Augustijns1, A D'Hulst, J Van Daele, R Kinget.   

Abstract

Artemisinin and its derivatives are becoming interesting alternatives to the commonly used antimalarial drugs because they are efficient in treating severe and multidrug resistant forms of Plasmodium falciparum malaria. A major drawback is the occurrence of recrudescence some time after treatment. Moderate oral bioavailability has been suggested as a possible cause. As one of the factors that might limit absorption after oral administration, we studied the intestinal permeability using an in vitro system of the intestinal mucosa, Caco-2. Concentrations of artemisinin were determined by UV after alkaline degradation, while for sodium artesunate, a capillary electrophoresis method was developed. Artemisinin easily crossed the epithelial cells by passive diffusion (Papp = 30.4 +/- 1.7 x 10(-6) cm s-1, pH 7.4). Permeability of the hemisuccinate analogue, sodium artesunate, was 8-fold lower (Papp = 4.0 +/- 0.4 x 10(-6) cm s-1 at pH 7.4) and strongly dependent on pH, which might result in site dependent resorption in an in vivo situation. Enzyme catalyzed ester hydrolysis of sodium artesunate in Caco-2 monolayers to the biologically active metabolite, dihydroartemisinin, was moderate. The results indicate that the transepithelial permeability is probably not a limiting factor in the overall absorption process after oral administration of artemisinin or sodium artesunate. Solubility, dissolution rate, stability, and first-pass metabolism are suggested as alternative limiting factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8773952     DOI: 10.1021/js960001i

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  19 in total

1.  Predicting the Disposition of the Antimalarial Drug Artesunate and Its Active Metabolite Dihydroartemisinin Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Ryan Arey; Brad Reisfeld
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Computational prediction of CNS drug exposure based on a novel in vivo dataset.

Authors:  Christel A S Bergström; Susan A Charman; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2012-06-29       Impact factor: 4.200

3.  Antiplasmodial activity of targeted zinc(II)-dipicolylamine complexes.

Authors:  Douglas R Rice; María de Lourdes Betancourt Mendiola; Claribel Murillo-Solano; Lisa A Checkley; Michael T Ferdig; Juan C Pizarro; Bradley D Smith
Journal:  Bioorg Med Chem       Date:  2017-03-27       Impact factor: 3.641

4.  A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction.

Authors:  Toufigh Gordi; Rujia Xie; Nguyen V Huong; Dinh X Huong; Mats O Karlsson; Michael Ashton
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

Review 5.  Pharmacokinetics of artemisinin-type compounds.

Authors:  V Navaratnam; S M Mansor; N W Sit; J Grace; Q Li; P Olliaro
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

Review 6.  Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria.

Authors:  P J de Vries; T K Dien
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

7.  In vitro lipolysis and intestinal transport of β-arteether-loaded lipid-based drug delivery systems.

Authors:  Patrick B Memvanga; Pierre Eloy; Eric M Gaigneaux; Véronique Préat
Journal:  Pharm Res       Date:  2013-06-06       Impact factor: 4.200

8.  Capillary electrophoresis for the assay of fixed-dose combination tablets of artesunate and amodiaquine.

Authors:  N'Cho Christophe Amin; Marie-Dominique Blanchin; Michèle Aké; Jérôme Montels; Huguette Fabre
Journal:  Malar J       Date:  2012-05-03       Impact factor: 2.979

9.  Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria.

Authors:  Carrie A Morris; Marie A Onyamboko; Edmund Capparelli; Matthew A Koch; Joseph Atibu; Vicky Lokomba; Macaya Douoguih; Jennifer Hemingway-Foday; David Wesche; Robert W Ryder; Carl Bose; Linda Wright; Antoinette K Tshefu; Steven Meshnick; Lawrence Fleckenstein
Journal:  Malar J       Date:  2011-05-08       Impact factor: 2.979

10.  pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members.

Authors:  Yitong J Zhang; Byron Gallis; Michio Taya; Shusheng Wang; Rodney J Y Ho; Tomikazu Sasaki
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.